Healthcare provider profile · identity verified

Kasey Michelle Eidson, M.D.

Family Practice · RICHMOND, KY · NPI 1437312311

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	410	91
Gabapentin	Gabapentin	299	55
Atorvastatin Calcium	Atorvastatin Calcium	270	73
Amlodipine Besylate	Amlodipine Besylate	222	55
Omeprazole	Omeprazole	213	63
Metformin Hcl Er	Metformin Hcl	176	56
Ozempic	Semaglutide	160	37
Lisinopril	Lisinopril	153	46
Rosuvastatin Calcium	Rosuvastatin Calcium	152	50
Furosemide	Furosemide	140	38
Valsartan	Valsartan	117	32
Amitriptyline Hcl	Amitriptyline Hcl	114	33
Allopurinol	Allopurinol	113	29
Escitalopram Oxalate	Escitalopram Oxalate	109	23
Hydrochlorothiazide	Hydrochlorothiazide	108	33
Pravastatin Sodium	Pravastatin Sodium	104	29
Sertraline Hcl	Sertraline Hcl	98	26
Fluoxetine Hcl	Fluoxetine Hcl	90	22
Pantoprazole Sodium	Pantoprazole Sodium	90	26
Metoprolol Succinate	Metoprolol Succinate	89	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	15
Losartan Potassium	Losartan Potassium	87	23
Cefdinir	Cefdinir	86	67
Meloxicam	Meloxicam	82	23
Myrbetriq	Mirabegron	78	18
Carvedilol	Carvedilol	77	15
Clopidogrel	Clopidogrel Bisulfate	77	19
Fluticasone Propionate	Fluticasone Propionate	75	28
Famotidine	Famotidine	74	26
Clonazepam	Clonazepam	70	suppressed
Ropinirole Hcl	Ropinirole Hcl	70	suppressed
Synthroid	Levothyroxine Sodium	70	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	14
Potassium Chloride	Potassium Chloride	66	18
Buspirone Hcl	Buspirone Hcl	65	12
Tamsulosin Hcl	Tamsulosin Hcl	65	17
Temazepam	Temazepam	65	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	64	27
Alprazolam	Alprazolam	64	14
Doxycycline Hyclate	Doxycycline Hyclate	63	48
Prednisone	Prednisone	62	37
Eliquis	Apixaban	61	16
Diclofenac Sodium	Diclofenac Sodium	60	22
Pregabalin	Pregabalin	60	suppressed
Glipizide Er	Glipizide	59	15
Duloxetine Hcl	Duloxetine Hcl	58	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	17
Tramadol Hcl	Tramadol Hcl	57	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	56	56
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	18
Bupropion Xl	Bupropion Hcl	55	16
Ibandronate Sodium	Ibandronate Sodium	55	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	55	14
Tizanidine Hcl	Tizanidine Hcl	55	12
Ondansetron Odt	Ondansetron	54	16
Trulicity	Dulaglutide	54	12
Mirtazapine	Mirtazapine	50	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	50	41
Metoprolol Tartrate	Metoprolol Tartrate	48	13
Montelukast Sodium	Montelukast Sodium	48	17
Metformin Hcl	Metformin Hcl	47	17
Januvia	Sitagliptin Phosphate	46	suppressed
Nebivolol Hcl	Nebivolol Hcl	46	12
Nystatin	Nystatin	46	24
Eszopiclone	Eszopiclone	43	suppressed
Farxiga	Dapagliflozin Propanediol	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Spironolactone	Spironolactone	43	13
Promethazine Hcl	Promethazine Hcl	42	suppressed
Fluconazole	Fluconazole	39	26
Venlafaxine Hcl Er	Venlafaxine Hcl	39	12
Warfarin Sodium	Warfarin Sodium	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	11
Celecoxib	Celecoxib	35	suppressed
Jardiance	Empagliflozin	35	12
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Colestipol Hcl	Colestipol Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Armodafinil	Armodafinil	28	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Estradiol	Estradiol	26	11
Ipratropium Bromide	Ipratropium Bromide	26	14
Movantik	Naloxegol Oxalate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	20
Glipizide	Glipizide	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Mirabegron Er	Mirabegron	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Levofloxacin	Levofloxacin	18	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Prolia	Denosumab	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Finasteride	Finasteride	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error